摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-fluoro-4-(2-fluoroethoxy)benzene | 659-36-9

中文名称
——
中文别名
——
英文名称
1-fluoro-4-(2-fluoroethoxy)benzene
英文别名
(2-fluoro-ethyl)-(4-fluoro-phenyl)-ether;(2-Fluor-aethyl)-(4-fluor-phenyl)-aether
1-fluoro-4-(2-fluoroethoxy)benzene化学式
CAS
659-36-9
化学式
C8H8F2O
mdl
——
分子量
158.148
InChiKey
GRYWYAYHEFAXFX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    201.4±20.0 °C(Predicted)
  • 密度:
    1.132±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-氟苯酚 在 potassium fluoride 、 N-苯基双(三氟甲烷磺酰)亚胺potassium carbonate 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 13.0h, 生成 1-fluoro-4-(2-fluoroethoxy)benzene
    参考文献:
    名称:
    以 KF 为氟源的醇直接脱氧氟化
    摘要:
    本报告描述了一种以 KF 作为氟源通过原位生成高活性 CF 3 SO 2 F 的醇脱氧氟化的方法。包括卤素、硝基、酮、酯、烯烃和炔烃在内的多种官能团具有良好的耐受性。温和的条件、短的反应时间和广泛的底物范围使该方法成为构建 C-F 键的绝佳选择。
    DOI:
    10.1021/acs.joc.2c00388
点击查看最新优质反应信息

文献信息

  • Triazolone derivatives
    申请人:Clark Richard
    公开号:US20080015199A1
    公开(公告)日:2008-01-17
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R 1a , R 1b , R 1c and R 1d each independently represent hydrogen, etc.; R 2 represents optionally substituted phenyl, etc.; R 3 represents optionally substituted C6-10 aryl, etc.; and Z 1 and Z 2 each independently represent hydrogen]
    以下一般式(1)表示的化合物,其盐或上述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成相关的疾病,并且具有适当的物理化学稳定性,更安全。 [其中R1a,R1b,R1c和R1d分别独立表示氢等;R2表示可选择取代的苯基等;R3表示可选择取代的C6-10芳基等;Z1和Z2分别独立表示氢]
  • TRIAZOLONE DERIVATIVES
    申请人:CLARK Richard
    公开号:US20100190783A1
    公开(公告)日:2010-07-29
    A Compound represented by the following general formula (1): wherein R 1a , R 1b , R 1c and R 1d each independently represent hydrogen, etc.; R 2 represents optionally substituted phenyl, etc.; R 3 represents optionally substituted C6-10 aryl, etc.; and Z 1 and Z 2 each independently represent hydrogen or salts thereof or hydrates of the foregoing.
    以下是通式(1)表示的化合物:其中R1a,R1b,R1c和R1d各自独立地表示氢等;R2表示可选取代的苯基等;R3表示可选取代的C6-10芳基等;Z1和Z2各自独立地表示氢或其盐或其合物。
  • TRIAZOLONE DERIVATIVE
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP2000465A1
    公开(公告)日:2008-12-10
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
    由以下通式(1)代表的化合物、其盐类或前述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成有关的疾病,且具有较高的安全性和适当的理化稳定性。 [其中 R1a、R1b、R1c 和 R1d 各自独立地代表氢等;R2 代表任选取代的苯基等;R3 代表任选取代的 C6-10 芳基等;Z1 和 Z2 各自独立地代表氢]
  • Triazolone derivative
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP2194046A1
    公开(公告)日:2010-06-09
    A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
    由以下通式(1)代表的化合物、其盐类或前述化合物的合物是一种新型化合物,可用于治疗和/或预防与血栓形成有关的疾病,且具有更高的安全性和适当的理化稳定性。 [其中 R1a、R1b、R1c 和 R1d 各自独立地代表氢等;R2 代表任选取代的苯基等;R3 代表任选取代的 C6-10 芳基等;Z1 和 Z2 各自独立地代表氢]
  • A Structural Equation Model of Parental Involvement, Motivational and Aptitudinal Characteristics, and Academic Achievement
    作者:Julio Antonio Gonzalez-pienda、Jose Carlos Nunez、Soledad Gonzalez-pumariega、Luis Alvarez、Cristina Roces、Marta Garcia
    DOI:10.1080/00220970209599509
    日期:2002.1
    The authors used the structural equation model (SEM) approach to test a model hypothesizing the influence of parental involvement on students' academic aptitudes, self-concept, and causal attributions, as well as the influence of the 3 variables on academic achievement. The theoretical model was contrasted in a group of 12- to 18-year-old adolescents (N = 261) attending various educational centers. The results indicate that (a) parental involvement had a positive and significant influence on the participant's measured characteristics; (b) causal attribution was not causally related to self-concept or academic achievement when the task involved finding causes for success, but, self-concept and causal attributions were found to be significantly and reciprocally related when the task involved finding causes accounting for failure; (c) self-concept was statistically and predominantly causally related to academic achievement, but not vice versa; and (d) aptitude and self-concept accounted for academic achievement, although the effect of self-concept was predominant. These results suggest that in adolescence, cognitive-affective variables become crucial in accounting for academic behavior.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯